LESIONED LOW-DENSITY-LIPOPROTEIN IN ATHEROSCLEROTIC APOLIPOPROTEIN E-DEFICIENT TRANSGENIC MICE AND IN HUMANS IS OXIDIZED AND AGGREGATED

被引:74
作者
AVIRAM, M
MAOR, I
KEIDAR, S
HAYEK, T
OIKNINE, J
BAREL, Y
ADLER, Z
KERTZMAN, V
MILO, S
机构
[1] TECHNION ISRAEL INST TECHNOL,BRUCE RAPPAPORT FAC MED,RAMBAM MED CTR,DEPT CARDIAC SURG,HAIFA,ISRAEL
[2] TECHNION ISRAEL INST TECHNOL,RAPPAPORT FAMILY INST RES MED SCI,IL-31096 HAIFA,ISRAEL
关键词
D O I
10.1006/bbrc.1995.2651
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We analyzed lesioned LDL in both atherosclerotic humans and in the apo E deficient (E degrees) mice and compared its characteristics to plasma LDL. Lesioned LDL, in comparison to plasma LDL, was minimally oxidized and aggregated. Upon incubation of E degrees-aortic lesions with (125)[I]-labeled LDL, a time-dependent oxidation of the lipoprotein occurred as evident by a rapid and substantial elevation in LDL-associated TBARS from 0.2 to 10.3 and 14.5 nmoles of MDA equivalents/mg LDL protein after 2 and 24 hours of incubation, respectively. Only minimal LDL aggregates could be detected after 2 hours of incubation. Extensive LDL aggregation (15%), however, occurred after 24h of incubation. Similar results were obtained on using human lesioned aortas. We conclude that both oxidation and aggregation of lesioned LDL could be the result of aortic lesioned-induced modification of the lipoprotein, and both of these modified forms of LDL can further contribute to the acceleration of the atherosclerotic process. (C) 1995 Academic Press, Inc.
引用
收藏
页码:501 / 513
页数:13
相关论文
共 43 条
  • [1] Fowler S., Acta Med. Scand, 642, pp. 151-158, (1980)
  • [2] Kruth H.S., Am. J. Phathol, 114, pp. 201-207, (1984)
  • [3] Chung B.H., Tallis G., Yalamaori V., Anantharamaiah G.M., Segrest J.P., Am. J. Phathol, 14, pp. 622-635, (1994)
  • [4] Chao F.F., Blanchette-Mackie E.J., Dickens B.F., Gamble W., Kruth H.S., J. Lipid Res, 35, pp. 71-83, (1994)
  • [5] Steinbrecher U.P., Lougheed M., Arteriosclerosis and Thrombosis, 12, pp. 608-625, (1992)
  • [6] Chao F.F., Blanchette-Mackie J., Chen Y.J., Dickens B.F., Berlin E., Amende L.M., Skarlatos S.I., Gamble W., Resau J.H., Am. J.Pathol., 136, pp. 169-179, (1990)
  • [7] Chao F.F., Amende L.M., Blanchette-Mackie E.J., Skarlotos S.I., Gamble W., Resau J.H., Mergner W.T., Kruth H.S., Am. J. of Pathol, 131, pp. 73-83, (1988)
  • [8] Shio H., Haley N.J., Fowler S., Lab. Invest, 41, 2, pp. 160-167, (1979)
  • [9] Yla-Herttuala S., Jaakkola O., Ehnholm C., Tikkanen M.J., Solakivi T., Sarkioja T., Nikkari T., J. Lipid Res., 29, pp. 563-572, (1988)
  • [10] Aviram M., Atherosclerosis, 98, pp. 1-9, (1993)